Details for New Drug Application (NDA): 207624
✉ Email this page to a colleague
The generic ingredient in SEVELAMER CARBONATE is sevelamer carbonate. There are thirty-two drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the sevelamer carbonate profile page.
Summary for 207624
Tradename: | SEVELAMER CARBONATE |
Applicant: | Aurobindo Pharma |
Ingredient: | sevelamer carbonate |
Patents: | 0 |
Pharmacology for NDA: 207624
Mechanism of Action | Phosphate Chelating Activity |
Suppliers and Packaging for NDA: 207624
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SEVELAMER CARBONATE | sevelamer carbonate | FOR SUSPENSION;ORAL | 207624 | ANDA | Aurobindo Pharma Limited | 65862-930 | 65862-930-90 | 90 POUCH in 1 CARTON (65862-930-90) / 1 POWDER, FOR SUSPENSION in 1 POUCH (65862-930-08) |
SEVELAMER CARBONATE | sevelamer carbonate | FOR SUSPENSION;ORAL | 207624 | ANDA | Aurobindo Pharma Limited | 65862-931 | 65862-931-90 | 90 POUCH in 1 CARTON (65862-931-90) / 1 POWDER, FOR SUSPENSION in 1 POUCH (65862-931-08) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 800MG/PACKET | ||||
Approval Date: | Jun 13, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 2.4GM/PACKET | ||||
Approval Date: | Jun 13, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription